BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2715830)

  • 1. Comparison of different radioactive renal agents in cisplatin-induced tubular toxicity in rats.
    McAfee JG; Subramanian G; Thomas FD; Hellwig B; Roskopf M
    J Nucl Med; 1989 May; 30(5):659-65. PubMed ID: 2715830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cyclosporine nephrotoxicity in rats with various renal radioactive agents.
    McAfee JG; Thomas FD; Subramanian G; Roskopf M; Hellwig B
    J Nucl Med; 1988 Sep; 29(9):1577-81. PubMed ID: 2842472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m DADS complexes as renal function and imaging agents: II. Biological comparison with iodine-131 hippuran.
    McAfee JG; Subramanian G; Schneider RF; Roskopf M; Lyons B; Ritter C; Zapf-Longo C; Palladino E; Thomas FD
    J Nucl Med; 1985 Apr; 26(4):375-84. PubMed ID: 3981257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different radioactive agents for the detection of renovascular hypertension with captopril in a rat model.
    McAfee JG; Kopecky RT; Thomas FD; Hellwig B; Roskopf M
    J Nucl Med; 1988 Apr; 29(4):509-15. PubMed ID: 3280751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of renal concentration of technetium-99m glucoheptonate.
    Lee HB; Blaufox MD
    J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of diffuse glomerular lesions in rats: I. Comparisons of conventional radioactive agents.
    McAfee JG; Thomas FD; Subramanian G; Lyons B; Roskopf M
    J Nucl Med; 1986 Apr; 27(4):502-12. PubMed ID: 3012028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.
    Oyen WJ; Claessens RA; van der Meer JW; Corstens FH
    J Nucl Med; 1992 Mar; 33(3):388-94. PubMed ID: 1740708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and clearance of 99mTc-labeled Arg-Gly-Asp (RGD) peptide in rats with ischemic acute renal failure.
    Noiri E; Goligorsky MS; Wang GJ; Wang J; Cabahug CJ; Sharma S; Rhodes BA; Som P
    J Am Soc Nephrol; 1996 Dec; 7(12):2682-8. PubMed ID: 8989749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake.
    de Lange MJ; Piers DA; Kosterink JG; van Luijk WH; Meijer S; de Zeeuw D; van der Hem GK
    J Nucl Med; 1989 Jul; 30(7):1219-23. PubMed ID: 2544699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m DTPA renal flow studies in Goldblatt hypertension.
    Nally JV; Clarke HS; Windham JP; Grecos GP; Gross ML; Potvin WJ
    J Nucl Med; 1985 Aug; 26(8):917-24. PubMed ID: 3897482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR; Kasina S; Eshima D; Johnson DL
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal handling of technetium-99m DMSA in rats with proximal tubular dysfunction.
    Provoost AP; Van Aken M
    J Nucl Med; 1985 Sep; 26(9):1063-7. PubMed ID: 2993552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of diffuse glomerular lesions in rats: II. Comparison of indium-111 cationic small macromolecules with technetium-99m DTPA.
    McAfee JG; Thomas FD; Subramanian G; Schneider RD; Lyons B; Roskopf M; Zapf-Longo C; Whaley D
    J Nucl Med; 1986 Apr; 27(4):513-20. PubMed ID: 2423665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-DTPA renal studies for acute tubular necrosis: specificity of dissociation between perfusion and clearance.
    Shanahan WS; Klingensmith WC; Weil R
    AJR Am J Roentgenol; 1981 Feb; 136(2):249-53. PubMed ID: 6781242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of 99mTc dimercaptosuccinic acid renal uptake for an assessment for individual kidney function.
    Kawamura J; Hosokawa S; Yoshida O; Fujita T; Ishii Y; Torizuka K
    J Urol; 1978 Mar; 119(3):305-9. PubMed ID: 642079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental drug-induced changes in renal function and biodistribution of 99mTc-MDP.
    McAfee JG; Singh A; Roskopf M; Ritter C; Lyons B; Schoonmaker JE; Thomas FD; Jones D
    Invest Radiol; 1983; 18(5):470-8. PubMed ID: 6227584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous measumrement of the renal excretion of 131I-hippuran and 99mTc-MAG3].
    Schroth HJ; Bialy J; Bühler M; Peters JW; Rink T; Schmidt M; Garth H
    Nuklearmedizin; 1994 Jun; 33(3):113-8. PubMed ID: 8090625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats.
    Láznícek M; Láznícková A; Budský F; Prokop J; Kopicka K
    Appl Radiat Isot; 1994 Sep; 45(9):949-53. PubMed ID: 7951182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.